-
2881por Osorio, E. Yaneth, Zhao, Weiguo, Espitia, Claudia, Saldarriaga, Omar, Hawel, Leo, Byus, Craig V., Travi, Bruno L., Melby, Peter C.“…The clinicopathological features of the hamster model of visceral leishmaniasis (VL) closely mimic active human disease. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2882por Moosa-Kazemi, SH, Shayeghi, M, Yaghoobi-Ershadi, MR, Vatandoost, H, Sadeghi, MT, Javadian, E, Motabar, M, Hosseini, MR, Abtahi, M“…BACKGROUND: The control of leishmaniasis, a tropical neglected disease, has been concern of Iranian health authorities due to the increasing number of cases during the last two decades. …”
Publicado 2009
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2883por Sun, Ke, Guan, Wang, Zhang, Jian-Guo, Wang, Ya-Jing, Tian, Yu, Liao, Lin, Yang, Bin-Bin, Chen, Da-Li, Chen, Jian-Ping“…BACKGROUND: Leishmaniasis is a vector-borne disease, which is still endemic in the west and northwest area of China. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2884por Cunha, Joana, Carrillo, Eugenia, Sánchez, Carmen, Cruz, Israel, Moreno, Javier, Cordeiro-da-Silva, Anabela“…BACKGROUND: Leishmaniasis is a group of diseases with a variety of clinical manifestations. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2885por de Oliveira, Fabrícia Alvisi, Vanessa Oliveira Silva, Carla, Damascena, Nayra Prata, Passos, Rodrigo Oliveira, Duthie, Malcolm S, Guderian, Jeffrey A, Bhatia, Ajay, de Moura, Tatiana Rodrigues, Reed, Steven G, de Almeida, Roque Pacheco, de Jesus, Amélia Ribeiro“…In this prospective study, we describe the sera kinetics of these two molecules in the course of treatment follow up in human visceral leishmaniasis (VL). METHODS: Sera from VL patients were collected before and during follow up of regular Antimony treatment. sCD40L and MMP-9 were measured by Luminex assay. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2886por Restrepo, Carlos M., De La Guardia, Carolina, Sousa, Octavio E., Calzada, José E., Fernández, Patricia L., Lleonart, Ricardo“…American Tegumentary Leishmaniasis is caused by parasites of the genus Leishmania, and causes significant health problems throughout the Americas. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2887“…In a model of experimental cutaneous leishmaniasis, pre-exposure of Leishmania major-resistant mice to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), an aryl hydrocarbon receptor agonist, causes suppression of the protective anti-parasite T helper 1 response while paradoxically also reducing parasite burdens in those animals. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2888por Pereira-Carvalho, Regina, Mendes-Aguiar, Carolina O., Oliveira-Neto, Manoel P., Covas, Cláudia J. F., Bertho, Álvaro L., Da-Cruz, Alda M., Gomes-Silva, Adriano“…Leishmania reactive CD4(+) and CD8(+) T cells are expanded in long-term healed cutaneous leishmaniasis (hCL) patients but their functional characteristics remain to be determined. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2889por Khalil, Eltahir A. G., Weldegebreal, Teklu, Younis, Brima M., Omollo, Raymond, Musa, Ahmed M., Hailu, Workagegnehu, Abuzaid, Abuzaid A., Dorlo, Thomas P. C., Hurissa, Zewdu, Yifru, Sisay, Haleke, William, Smith, Peter G., Ellis, Sally, Balasegaram, Manica, EL-Hassan, Ahmed M., Schoone, Gerard J., Wasunna, Monique, Kimutai, Robert, Edwards, Tansy, Hailu, Asrat“…BACKGROUND: Anti-leishmanial drug regimens that include a single dose AmBisome® could be suitable for eastern African patients with symptomatic visceral leishmaniasis (VL) but the appropriate single dose is unknown. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2890“…The parasite responsible for autochthonous cutaneous leishmaniasis in Martinique island (French West Indies) was first isolated in 1995; its taxonomical position was established only in 2002, but it remained unnamed. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2891por Bray, Daniel P., Carter, Vicky, Alves, Graziella B., Brazil, Reginaldo P., Bandi, Krishna K., Hamilton, James G. C.“…Current control methodologies have not prevented the spread of visceral leishmaniasis (VL) across Brazil. Here, we describe the development of a new tool for controlling the sand fly vector of the disease: a long-lasting lure, which releases a synthetic male sex pheromone, attractive to both sexes of Lutzomyia longipalpis. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2892por Vilela, Maurício Luiz, de Pita-Pereira, Daniela, Azevedo, Carina Graser, Godoy, Rodrigo Espíndola, Britto, Constança, Rangel, Elizabeth Ferreira“…Phlebotomine sandflies were captured in rural settlement and periurban areas of the municipality of Guaraí in the state of Tocantins (TO), an endemic area of American cutaneous leishmaniasis (ACL). Forty-three phlebotomine species were identified, nine of which have already been recognised as ACL vectors. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2893“…Leishmania tropica was isolated from the clinical patients of cutaneous leishmaniasis in rural community of Kohat district in Khyber Pakhtunkhwa province and was identified through PCR, microscopy, and culture techniques. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2894por Nilforoushzadeh, Mohammad Ali, Shirani-Bidabadi, Leila, Saberi, Sedigheh, Hosseini, Seyed Mohsen, Jaffary, Fariba“…BACKGROUND: Cutaneous leishmaniasis (CL) is still considered as a health problem in the world. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2895por Osorio, E. Yaneth, Travi, Bruno L., da Cruz, Alda M., Saldarriaga, Omar A., Medina, Audrie A., Melby, Peter C.“…Host arginase 1 (arg1) expression is a significant contributor to the pathogenesis of progressive visceral leishmaniasis (VL), a neglected tropical disease caused by the intracellular protozoan Leishmania donovani. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2896por Sangenis, Luiz Henrique Conde, Lima, Sebastião Roberto de Almeida, de Mello, Cíntia Xavier, Cardoso, Daniela Trindade, Mello, Jurema Nunes, do Espírito Santo, Maria Cristina Carvalho, Tavares, Walter“…Visceral Leishmaniasis has been showing remarkable epidemiological changes in recent decades, with marked expansion and an emergence of cases in urban areas of the North, Southeast and Midwest regions of Brazil. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2897
-
2898por Burza, Sakib, Mahajan, Raman, Sinha, Prabhat K., van Griensven, Johan, Pandey, Krishna, Lima, María Angeles, Sanz, Marta Gonzalez, Sunyoto, Temmy, Kumar, Sunil, Mitra, Gaurab, Kumar, Ranjeet, Verma, Neena, Das, Pradeep“…BACKGROUND: Visceral Leishmaniasis (VL; also known as kala-azar) is an ultimately fatal disease endemic in the Indian state of Bihar, while HIV/AIDS is an emerging disease in this region. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2899por Fortin, Anny, Caridha, Diana P., Leed, Susan, Ngundam, Franklyn, Sena, Jenell, Bosschaerts, Tom, Parriott, Sandi, Hickman, Mark R., Hudson, Thomas H., Grogl, Max“…BACKGROUND: Cutaneous leishmaniasis (CL) represents a range of skin diseases caused by infection with Leishmania parasites and associated with tissue inflammation and skin ulceration. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2900por Sundar, Shyam, Pandey, Krishna, Thakur, Chandreshwar Prasad, Jha, Tara Kant, Das, Vidya Nand Ravi, Verma, Neena, Lal, Chandra Shekhar, Verma, Deepak, Alam, Shahnawaz, Das, Pradeep“…BACKGROUND: India is home to 60% of the total global visceral leishmaniasis (VL) population. Use of long-term oral (e.g. miltefosine) and parenteral drugs, considered the mainstay for treatment of VL, is now faced with increased resistance, decreased efficacy, low compliance and safety issues. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto